eClinical Solutions Global Market Report 2022

eClinical Solutions Global Market Report 2022

  • August 2022 •
  • 175 pages •
  • Report ID: 6311743 •
  • Format: PDF
Major players in the eclinical solutions market are Anju Software Inc., BioClinicia Inc., Parexel International Corporation, CRF Health, Dassault Systèmes, Datatrak International Inc., Eclinical Solutions LLC, ERT Clinical, IBM Watson Health, Medidata Solutions Inc., Omnicomm Systems Inc., Veeva Systems Inc., Mednet Solutions, and Cinven

The global eclinical solutions market is expected to grow from $5.97 billion in 2021 to $7.00 billion in 2022 at a compound annual growth rate (CAGR) of 17.2%. The eclinical solutions market is expected to grow to $11.60 billion in 2026 at a CAGR of 13.5%.

The eclinical solutions market consists of sales of eclinical solutions and services by entities (organizations, sole traders, partnerships) that are used in the clinical development process by combining clinical technology expertise. eClinical solutions refer to the use of computerized solutions and related procedures to aid clinical trial operations by automating previously laborious tasks. eClinical has evolved to include a wide range of technologies that aim to help with one or more phases of clinical trials, from planning through submissions and data mining.

The main types of eclinical solutions are electronic data capture (EDC) and clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platforms, randomization and trial supply management (RTSM), clinical data integration platforms, electronic clinical outcome assessment (ECOA), safety solutions, and electronic trial master file (ETMF).The Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) markets refer to a program that allows a person to capture and collect clinical documents.

The various delivery modes include web-based, cloud-based, and enterprise-based, which have various development phases such as phase I, phase II, phase III, and phase Iv. It is employed in several sectors, such as pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions.

North America was the largest region in the eclinical solutions market in 2021. The regions covered in the eclinical solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The eclinical solutions market research report is one of a series of new reports that provides eclinical solutions market statistics, including global market size, regional shares, competitors with a eclinical solutions market share, detailed eclinical solutions market segments, market trends and opportunities, and any further data you may need to thrive in the eclinical solutions industry. This eclinical solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Increasing research and development expenditure on drug development pipelines by pharma-biotech companies is expected to propel the growth of the eClinical solutions market going forward.Companies are undergoing research and development on eclinical solutions for drug development to strengthen their position.

For instance, in 2020, Incyte, a US-based biopharmaceutical company, increased its R & D cost for drug development to $2.216 billion. They amounted to $1.1 billion in 2019. However, the majority of the rise was due to an increase in clinical research and outside services. The company spent $677 million on these goods in 2019. The sum grew to $1.701 billion in the year 2020. Therefore, the increase in spending on R & D on drug development is driving the growth of eClinical solutions.

Technological advancements have emerged as the key trend gaining popularity in the eClinical solutions market.Key players operating in the eClinical solutions sector are focusing on the use of advanced technologies to meet consumer demand.

For instance, in July 2021, eClinical Solutions LLC, an India-based provider of cloud-based enterprise software and software-driven clinical data services, released the Elluminate Clinical Data Cloud, based on cloud computing and real-time data analysis technologies. This has unique capabilities that help to improve the automation of both clinical and operational data streams across the platform, and it’s useful for automating the clinical operations data pipeline for speedier decision making.

In August 2020, GI Partners, a US-based private investment firm, acquired Clinical Ink Inc. for an undisclosed amount. Through this acquisition, GI Partners accelerates clinical Ink’s innovation in clinical trial workflow solutions. Clinical Ink, Inc. is a US-based clinical trial technology company that provides electronic source records and other clinical trials.

The countries covered in the eclinical solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.